World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
64
Citations
15032
World Ranking
2931
National Ranking
31

Overview

Luis Escribano is affiliated with the University of Salamanca in Spain. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a focus on several interconnected subfields including Immunology, Physiology, Immunology and Allergy, Pharmacology, and Rheumatology.

The core topics covered in their work include:

  • Mast cells and histamine
  • Asthma and respiratory diseases
  • Allergic Rhinitis and Sensitization
  • Drug-Induced Adverse Reactions
  • Urticaria and Related Conditions
  • Social Sciences and Policies

Escribano's recent publications demonstrate their engagement with both biomedical and social scientific research. Notable papers include:

  • "Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts", 2020, published in Theranostics
  • "Mastocytosis presenting with mast cell-mediator release-associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features", 2022, published in Clinical and Translational Allergy
  • "Evaluación de la investigación social", 2024, published in Revista Española de Investigaciones Sociológicas

These publications highlight contributions to understanding mast cell biology and clinical features related to mastocytosis, as well as social science investigations relevant to research evaluation.

Frequent co-authors collaborating with Escribano include:

  • Alberto Órfão
  • Peter Valent
  • Cem Akin
  • Karin Hartmann
  • Gunnar Nilsson

Escribano's work is published across a range of journals reflecting both their biomedical and social research interests. Key publication venues include:

  • Theranostics
  • Clinical and Translational Allergy
  • Revista Española de Investigaciones Sociológicas

Best Publications

  • Diagnostic criteria and classification of mastocytosis: a consensus proposal

    Peter Valent;Hans P. Horny;Luis Escribano;B. Jack Longley

  • Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.

    P. Valent;C. Akin;L. Escribano;M. Födinger

  • Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal

    Peter Valent;Cem Akin;Michel Arock;Knut Brockow

  • KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients.

    Andres C Garcia-Montero;Maria Jara-Acevedo;Cristina Teodosio;Maria Luz Sanchez

  • Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

    Karin Hartmann;Luis Escribano;Clive Grattan;Knut Brockow

  • Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients.

    Luis Escribano;Iván Álvarez-Twose;Laura Sánchez-Muñoz;Andres Garcia-Montero

  • Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.

    M. Ocqueteau;A. Orfao;J. Almeida;J. Bladé

  • KIT mutation analysis in mast cell neoplasms : recommendations of the European Competence Network on Mastocytosis

    Michel Arock;Karl Sotlar;Cem Akin;Sigurd Broesby-Olsen

  • Indolent Systemic Mast Cell Disease in Adults: Immunophenotypic Characterization of Bone Marrow Mast Cells and Its Diagnostic Implications

    Luis Escribano;Alberto Orfao;Alberto Orfao;Beatriz Dı́az-Agustin;Beatriz Dı́az-Agustin;Jesús Villarrubia;Jesús Villarrubia

  • Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria

    Peter Valent;Cem Akin;Wolfgang R. Sperr;Luis Escribano

  • Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.

    Iván Álvarez-Twose;David González de Olano;Laura Sánchez-Muñoz;Almudena Matito

  • Recent advances in the understanding of mastocytosis: the role of KIT mutations*

    Alberto Orfao;Andrés C. Garcia-Montero;Laura Sanchez;Luis Escribano

  • Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future

    Peter Valent;Cem Akin;Karin Hartmann;Gunnar Nilsson

  • Mastocytosis: current concepts in diagnosis and treatment.

    L Escribano;C Akin;M Castells;A Orfao

  • Serum Tryptase Levels in Patients with Mastocytosis: Correlation with Mast Cell Burden and Implication for Defining the Category of Disease

    Wolfgang R. Sperr;John-Hendrik Jordan;Michael Fiegl;Luis Escribano

  • Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis

    Wolfgang R Sperr;Luis Escribano;John-Hendrik Jordan;Gerit-Holger Schernthaner

  • One-Step Detection of c-kit Point Mutations Using Peptide Nucleic Acid-Mediated Polymerase Chain Reaction Clamping and Hybridization Probes

    Karl Sotlar;Luis Escribano;Olfert Landt;Stefanie Möhrle

  • Immunophenotypic analysis of Waldenstrom's macroglobulinemia

    J.F. San Miguel;M.B. Vidriales;E. Ocio;G. Mateo

  • Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations.

    Mariana Castells;Dean D. Metcalfe;Luis Escribano

  • Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis

    I. Alvarez-Twose;S. Vañó-Galván;L. Sánchez-Muñoz;J. M. Morgado

  • Expression of the c-kit (CD117) Molecule in Normal and Malignant Hematopoiesis

    L Escribano;M Ocqueteau;J Almeida;A Orfao

  • Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma

    M P Purdue;Q Lan;T J Kemp;A Hildesheim

Frequent Co-Authors

Alberto Orfao
Alberto Orfao University of Salamanca
Peter Valent
Peter Valent Medical University of Vienna
Cem Akin
Cem Akin University of Michigan–Ann Arbor
Lawrence B. Schwartz
Lawrence B. Schwartz Virginia Commonwealth University
Dean D. Metcalfe
Dean D. Metcalfe National Institute of Allergy and Infectious Diseases
Julia Almeida
Julia Almeida University of Salamanca
Karin Hartmann
Karin Hartmann University Hospital of Basel
Massimo Triggiani
Massimo Triggiani University of Salerno
Knut Brockow
Knut Brockow Technical University of Munich
Mariana Castells
Mariana Castells Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career pathways. Many professionals transition into specialized roles by enrolling in programs like acute care certification for fnp, which prepares family nurse practitioners for critical patient care environments.

Accelerated programs offer a fast track for those looking to advance quickly in nursing. Options such as an accelerated nurse practitioner program provide flexible online study with rigorous training, ideal for building specialized knowledge in immune-related healthcare.

For individuals without a nursing background, enrolling in online rn programs for non nurses in florida can be a vital step toward entering the healthcare field, enabling them to gain foundational skills before focusing on immunology-related roles.

Additionally, exploring accelerated nursing programs can simplify the pathway into nursing, providing an expedited route to earning a Bachelor of Science in Nursing (BSN) and eventually specializing in immunology or related fields.

Best Scientists Citing Luis Escribano

Trending Scientists

Recently Published Articles